EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Circulating Molecular Biomarkers for the Diagnosis and Monitoring of NSCLC—A Review

Wojciech Jelski, Sylwia Okrasinska, Weronika Rutkowska, Barbara Mroczko iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110278 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Wojciech Jelski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical Diagnostics, Medical University, 15-269 Bialystok, Poland. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Biomarkers, Tumor, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small cell lung cancer (NSCLC) is a severe disease with a very poor prognosis. Some 30–80% of patients with NSCLC die within five years of cancer diagnosis. The main factors contributing to this condition are the lack of effective markers for diagnosing cancer at an early stage, as well as the complexity of the biological processes involved in tumorigenesis and progression. The development of knowledge regarding all aspects of NSCLC has provided information used in the detection, systemic anticancer therapy and monitoring of NSCLC, which has a significant impact on prognosis and quality of life. NSCLCs release various biological substances into the bloodstream. Liquid biopsies allow for the analysis of tumor components in body fluids, and the usefulness of these biopsy tests as a substitute for tumor tissue is increasing. In this article, we critically review the available literature on microRNAs, circulating cell-free DNA (cfDNA), tumor-educated platelets (TEPs), circulating tumor cells (CTCs), circulating extracellular vesicles (EVs), and metabolomic and proteomic markers in the diagnosis and monitoring of NSCLC. However, the usefulness of these new markers in clinical practice has significant limitations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungBiomarkers, TumorLung NeoplasmsHumansNeoplastic Cells, CirculatingExtracellular VesiclesLiquid BiopsyCell-Free Nucleic AcidsMicroRNAsPrognosis

Stichwörter der Autor:innen

non-small cell lung cancertumor biomarkers

Substanzen

Biomarkers, TumorCell-Free Nucleic AcidsMicroRNAs

Autor:innen und Institutionen

  • Department of Biochemical Diagnostics, Medical University, 15-269 Bialystok, Poland.
  • Department of Biochemical Diagnostics, University Hospital, 15-269 Bialystok, Poland.
  • Department of Neurodegeneration Diagnostics, Medical University, 15-269 Bialystok, Poland.

ORCID-Profile: Barbara Mroczko

Zitieren

APA

Jelski, W., Okrasinska, S., Rutkowska, W., & Mroczko, B. (2025). Circulating Molecular Biomarkers for the Diagnosis and Monitoring of NSCLC—A Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110278

Vancouver

Jelski W, Okrasinska S, Rutkowska W, Mroczko B. Circulating Molecular Biomarkers for the Diagnosis and Monitoring of NSCLC—A Review. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110278

BibTeX
@article{Jelski2025,
  author = {Jelski, Wojciech and Okrasinska, Sylwia and Rutkowska, Weronika and Mroczko, Barbara},
  title = {Circulating Molecular Biomarkers for the Diagnosis and Monitoring of NSCLC—A Review},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110278}
}
Kostenlos starten →